Ben Goldacre

See the following -

Bad Pharma: Account Of The Bottomless Corruption Of The Pharma Industry Is A Stirring Call To Arms

Cory Doctorow | Boing Boing | November 6, 2012

I mentioned in September that Ben "Bad Science" Goldacre had a new book out, Bad Pharma: How drug companies mislead doctors and harm patients. I was sure at the time that this would be the usual excellent Goldacre fare -- lucid, thorough, and important. Now that I'm back from my own book tour, I've had a chance to read it and I'm pleased (or rather, furious -- more on this later) to report that this really is the usual, excellent Goldacre stuff. Read More »

Big Pharma Plays Hide-The-Ball With Data

Ben Wolford | Newsweek | November 13, 2014

...[E]vidence released earlier this year by  Cochrane Collaboration, a London-based nonprofit, shows that a significant amount of negative data from [Tamiflu's] clinical trials were hidden from the public. The Food and Drug Administration (FDA) knew about it, but the medical community did not; the U.S. Centers for Disease Control and Prevention (CDC), which doesn’t have the same access to unpublished data as regulators, had recommended the drug without being able to see the full picture...

Read More »

Health Committee: Hidden Trial Data Should Be Opened Up

Maeve McClenaghan | The Bureau of Investigative Journalism (BiJ) | January 16, 2013

The pharmaceutical industry should introduce a new code of practice, ensuring negative trial data cannot be hidden, according to the government’s Health Committee. Read More »

How Scrutiny Of Freely Available Data Might Save The NHS Money

Staff Writer | The Economist | December 8, 2012

This week Britons were reminded yet again of the strains on the government’s finances. But another resource—data—is in abundant supply. Like governments in many other countries, Britain’s is turning more and more of its trove of information into “open data”... Read More »

Open Data Probe Shows NHS Statin Bill Twice What It Should Be

Staff Writer | British Journal of Healthcare Computing | July 12, 2012

A start up using some of the flood of new government data being published says the NHS could make considerable savings on its drug expenditure if it wanted. Does it have a point? Read More »

Open Data Projects Win Wellcome Trust, NIH and HHMI Open Science Prize

The Open Science Prize, a new initiative from the US National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI) and the Wellcome Trust, encourages and supports open science approaches that generate benefit to society, advance research and spur innovation. An integral component of the selection process is demonstrated use and generation of open data, so PLOS is proud that this year’s winner of the Open Science Prize is PLOS author and evolutionary, computational biologist Trevor Bedford of the Fred Hutchinson Cancer Research Center in Seattle, Washington...

Open Health Data: An International Snapshot

Eugene Borukhovich | Health 2.0 News | January 23, 2013

The 2009 Digital Britain Report described data as ‘an innovation currency’ and ‘the lifeblood of the knowledge economy.’  We are now in 2013 and while there is tremendous buzz around open data in general, open health data is definitely lagging behind. Read More »

Open-access prescription data can save Britain's NHS millions: study

Lynne Taylor | Pharma Times Online | January 8, 2013

A study backed by the NHS Commissioning Board (NHSCB) has found that the sharing of publicly-available prescribing data could save the NHS in England millions of pounds a year. Read More »

Richard Smith: Is The Pharmaceutical Industry Like The Mafia?

Richard Smith | BMJ Group | September 10, 2013

There must be plenty of people who shudder when they hear that Peter  Gøtzsche will be speaking at a meeting or see his name  on the contents list of a journal. He is like the young boy who not only could see that the emperor had no clothes but also said so. [...] Read More »

What Clinical Trial Results? Now You Can See Who Isn’t Sharing Their Findings

Ed Silverman | STAT | November 3, 2016

The results for nearly half of all clinical trials conducted by big drug makers during the last decade have not been published, and one company — Ranbaxy Laboratories — has not published findings for any of the nearly three dozen trials conducted in the past 10 years, according to a new online tool. The tool was launched Thursday by AllTrials, a consortium of researchers and medical journals that has been pushing the pharmaceutical industry to do a better job of disclosing clinical trial data...

Read More »

Why All Pharmaceutical Research Should Be Made Open Access

Cory Doctorow | The Guardian | November 20, 2012

The government wants to make all publicly funded research available – but the same must be demanded of pharmas also Read More »